Clinical Trials Browser

Phase 2 × OTHER_GOV × Etoposide × Clear all

NCT06786312 2025-01-22

A Single-arm, Multicenter, Prospective Phase II Clinical Study of Apatinib in Combination With Adebrelimab and EC Regimen in the First-line Treatment of Extensive Small Cell Lung Cancer

Phase 2 Not yet recruiting

Small Cell Lung Carcinoma

NCT03389087 2020-07-10

Study of Apatinib Plus Etoposide Capsule as the Therapy of Advanced Small Cell Lung Cancer

Phase 2 Unknown

Small Cell Lung Carcinoma

NCT03963193 2019-05-24

Etoposide/Cisplatin Compared With Irinotecan/Cisplatin for Advanced Gastrointestinal Neuroendocrine Tumor G3 Type

Phase 2 Unknown

EndocrineGastrointestinalNET

Gastro-enteropancreatic neuroendocrine tumor

NCT01669226 2016-12-19

AICE

Phase 2 Completed

Fallopian Tube Neoplasms, Ovarian Neoplasms